CSafe launches transport packaging for gene therapy market

By Damian Brett

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market.

CSafe said the passive AcuTemp Plus Series of packaging solutions has been designed with “proprietary, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures”. 

“We are proud to expand our cold chain packaging offerings for the cell and gene therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” stated Patrick Schafer, chief executive of CSafe Global.

“Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”

Share this story
Facebook
Twitter
LinkedIn

Related topics

Latest pharma logistics news

Atlanta Dachser receives IATA CEIV Pharma certification

By Rachelle Harry

Logistics company Dachser has achieved IATA CEIV Pharma certification for four of its locations: Frankfurt, Germany; Mumbai and Hyderabad, India;…

Read More

UPS announces new president HCLS unit

By Rachelle Harry

UPS has announced its new president of global helathcare and life sciences (HCLS) unit: Wes Wheeler. Wheeler’s appointment follows UPS’s…

Read More

CSafe launches transport packaging for gene therapy market

By Damian Brett

Pharma packaging firm CSafe Global has launched a new product for the cell and gene therapy market. CSafe said the…

Read More